-transparent.png){kind=logo}
The acetylation rate of sulfamethazine was studied in 25 patients with systemic lupus erythematosus (SLE). Seventeen of 25SLE patients, 68%, were slow acetylators compared to the reported incidence of 52% in the general population. There was no correlation between the acetylator phenotype in SLE patients and the various clinical manifestations or the activity of the disease. Lupus patients who were slow acetylators had a lower lymphocyte response to phytomitogens compared to rapid acetylators.
Related Publications
B Foad, and
A Litwin, and
H Zimmer, and
E V Hess
May 1980,
Arthritis and rheumatism,
B Foad, and
A Litwin, and
H Zimmer, and
E V Hess
January 1981,
Acta medica Scandinavica,
B Foad, and
A Litwin, and
H Zimmer, and
E V Hess
November 1986,
Arthritis and rheumatism,
B Foad, and
A Litwin, and
H Zimmer, and
E V Hess
September 1987,
Arthritis and rheumatism,
B Foad, and
A Litwin, and
H Zimmer, and
E V Hess
January 2005,
Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit,
B Foad, and
A Litwin, and
H Zimmer, and
E V Hess
January 1974,
Drug metabolism and disposition: the biological fate of chemicals,
B Foad, and
A Litwin, and
H Zimmer, and
E V Hess
January 1981,
Clinical pharmacokinetics,
B Foad, and
A Litwin, and
H Zimmer, and
E V Hess
June 1985,
Singapore medical journal,
B Foad, and
A Litwin, and
H Zimmer, and
E V Hess
October 2004,
Saudi medical journal,
B Foad, and
A Litwin, and
H Zimmer, and
E V Hess
October 1981,
Arthritis and rheumatism,
